The goal of this program is to improve use of newer drugs for breast cancer (BC). After hearing and assimilating this program, the clinician will be better able to:Use estrogen receptor-targeting drugs in patients with BC.Differentiate various types of ESR1 mutations associated with endocrine resistance in BC.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2023-02-02 06:00:00
- End Date: 2023-02-02 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest